Dendritic Cell-Based Immunotherapy: The Importance of Dendritic Cell Migration

Figure 1

Clinical trials of DC-based antitumor immunotherapies: (a) DC-based anticancer immunotherapy was reported in different stages in clinical trials until July 2023; (b) distribution of status in current clinical trials among different types of cancer. “Other” includes bladder cancer, Ewing’s sarcoma, gastric cancer, head and neck cancer, hepatocellular carcinoma, liver cancer, malignant mesothelioma, soft tissue sarcoma, and uveal melanoma. DC; dendritic cell.

(a)

(b)